Percutaneous Coronary Intervention (PPCI) vs. Phrmaco-Invasive Approach for ST-Segment Elevated Myocardial Infarction (STEMI): A Systematic Review and Meta-Analysis | Synapse
March 9, 2026SN Comprehensive Clinical Medicine0 citations
Percutaneous Coronary Intervention (PPCI) vs. Phrmaco-Invasive Approach for ST-Segment Elevated Myocardial Infarction (STEMI): A Systematic Review and Meta-Analysis
To compare the effectiveness of percutaneous coronary intervention (PPCI) and pharmacoinvasive approach in treating ST-segment elevation myocardial infarction (STEMI).
Conducted a systematic review and meta-analysis of relevant studies
Assessing clinical outcomes associated with PPCI and pharmacoinvasive approach
Inclusion of multiple studies evaluating STEMI treatment outcomes
PPCI showed a significant improvement in clinical outcomes compared to pharmacoinvasive approach.
Patients receiving PPCI had lower rates of major adverse cardiac events, with a risk ratio of 0.75 (95% CI, 0.65-0.85, p<0.001).
Mortality rates were significantly lower in the PPCI group, with an odds ratio of 0.65 (95% CI, 0.50-0.85, p=0.002).